Streptococcus agalactiae Lehmann and Neumann (ATCC® BAA-23)

Strain Designations: CJB 111  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations CJB 111
Application
Produces capsular polysaccharide type V
Isolation
Blood, 1990
Type Strain no
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype V (Carol J Baker, personal communication)
Product Format freeze-dried
Preceptrol® no
Genome Sequenced Strain

Yes

Type Strain no
Antigenic Properties Serotype V (Carol J Baker, personal communication)
Comments
Genome sequenced strain
Name of Depositor CJ Baker
Special Collection NCRR Contract
Isolation
Blood, 1990
Year of Origin 1990
References

Carol J Baker, personal communication

Tettelin H, et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. USA. 102(39): 13950-13955, 2005. PubMed: 16172379

Carol J Baker, personal communication

Carol J Baker, personal communication

Cross References

Nucleotide (GenBank) : AAJQ01000000 Streptococcus agalactiae CJB111, whole genome shotgun sequencing project

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation